Systemic gaps in rare disease care: Age-based approvals and policy failures leave adults without life-saving treatments
Original framing: “Opinion: My brother can’t access a just-approved breakthrough drug for his rare disease” — STAT News
The article centers the voice of the author's brother, an adult with a rare disease, and critiques how systemic failures marginalize people like him. It also highlights the broader exclusion of adults from clinical trials and treatment access, making it a strong representation of marginalized perspectives.
The article reveals a systemic failure in rare disease care where policy and regulatory frameworks prioritize pediatric populations at the expense of adults, perpetuating exclusion and suffering.
By integrating Indigenous and cross-cultural perspectives, we can expand the understanding of health beyond biomedical models and embrace holistic care. Scientific and policy reforms are necessary to ensure equitable access, while the voices of marginalized adults must be centered in decision-making. A trickster lens exposes the irony of 'breakthrough' narratives that exclude those they claim to help, urging a reimagining of healthcare systems that values all lives equally across the lifespan.